Shade

📍 New York, United States🗓 Founded 2014👥 12 employees💰 Last funded Jan 2016
Backed by early-stage VCs and the National Cancer Institute of Health of the NIH, Shade is a spin-off of the Jacobs Technion-Cornell Institute in New York and a Highway1/PCH graduate that is re-inventing the standard of care in dermatology for photosensitive diseases (skin cancer, autoimmune disorders like lupus, etc.). Shade has built a proprietary and differentiable medical-grade wearable ultraviolet sensor that is 10x more accurate than anything else on the market. The sensor connects to the smartphone, enabling a rich interaction with users and unprecedented data collection about the impact of ultraviolet exposure on health. The Shade team is comprised of scientists and engineers with a deep expertise in semiconductors, artificial intelligence, manufacturing, and epidemiology, and is backed by a strong medical advisory board.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Shade?
Shade has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Shade last raise funding?
The most recent investment in Shade recorded on gritt.io was in January 2016.
When was Shade founded?
Shade was founded in 2014.
What industry is Shade in?
Shade operates in Semiconductor Manufacturing. Find similar Semiconductor Manufacturing investors on gritt.io.
Where is Shade based?
Shade is headquartered in New York, United States.